Boutin, J., Rosier, J., Cappellen, D., Prat, F., Toutain, J., Pennamen, P., . . . Bedel, A. (2021). CRISPR-Cas9 globin editing can induce megabase-scale copy-neutral losses of heterozygosity in hematopoietic cells. Nature Portfolio.
Chicago Style (17th ed.) CitationBoutin, J., et al. CRISPR-Cas9 Globin Editing Can Induce Megabase-scale Copy-neutral Losses of Heterozygosity in Hematopoietic Cells. Nature Portfolio, 2021.
MLA (8th ed.) CitationBoutin, J., et al. CRISPR-Cas9 Globin Editing Can Induce Megabase-scale Copy-neutral Losses of Heterozygosity in Hematopoietic Cells. Nature Portfolio, 2021.
Warning: These citations may not always be 100% accurate.